EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,617,000 | +9.0% | 749,502 | +87.6% | 0.52% | +7.0% |
| Q3 2018 | $4,235,000 | +1.8% | 399,502 | +30.1% | 0.49% | -15.3% |
| Q2 2018 | $4,162,000 | +115.8% | 307,154 | +104.8% | 0.57% | +133.3% |
| Q3 2015 | $1,929,000 | -31.5% | 150,000 | 0.0% | 0.25% | -16.0% |
| Q1 2015 | $2,817,000 | +107.7% | 150,000 | +200.0% | 0.29% | +74.4% |
| Q3 2014 | $1,356,000 | -61.5% | 50,000 | -55.8% | 0.17% | -80.6% |
| Q2 2014 | $3,522,000 | – | 113,188 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |